4.8 Review

Nanomedicine-based treatment: An emerging therapeutical strategy for pulmonary hypertension

期刊

NANO RESEARCH
卷 16, 期 5, 页码 7007-7029

出版社

TSINGHUA UNIV PRESS
DOI: 10.1007/s12274-022-5310-6

关键词

pulmonary hypertension; nanomedicines; enhanced penetration and retention effects; polymer; liposome

向作者/读者索取更多资源

Pulmonary hypertension (PH) is a deadly disease with a high incidence and limited treatment options. Nanomedicines have shown great potential in the treatment of PH by improving drug delivery, enhancing drug efficacy, and reducing side effects. However, there are significant professional barriers hindering the exploration of this promising field. This comprehensive review provides an overview of the pathological features of PH, current treatment options, and the progress of nanomedicines in PH treatment.
Pulmonary hypertension (PH) can cause breathing difficulty, a rapid decline of exercise capacity, heart failure, and eventually death of the patients. The latest epidemiological study demonstrates that PH has a much higher incidence than previously thought. PH is still a highly fatal disease due to the many disadvantages of the current drugs, such as short half-life, lack of targeting, and potent side effects. The PH pathological features offer great opportunities for nanomedicines for PH. Recently, emerging nanomedicines demonstrated great advantages in the therapeutic effect of PH by enhancing the accumulation of drugs in PH lesion, optimizing drug efficacy, and minimizing drug side effects. However, this promising field of cross -cutting research is far from being widely explored due to the huge professional barriers. To solve this problem, we provide a comprehensive review for the latest progresses of nanomedicines in the treatment of PH. Firstly, we systematical summarized the PH pathological features and the current clinical drug treatment of PH. The advantages of nanomedicines are also deeply discussed in the treatment of PH. Subsequently, we focused on the research progresses of nanomedicines in PH through three aspects: advanced nano -drug delivery system for traditional drugs and new target drugs, gene therapy -based nanomedicines, and other nanomedicines for the treatment of PH. Finally, we also discussed the prospects and challenges for the clinical application of nanomedicines in PH, and provided directions for the research and development of nanomedicines for PH treatment in the future.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据